Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

The globoside receptor triggers structural changes in the B19 virus capsid that facilitate virus internalization.

Bönsch C, Zuercher C, Lieby P, Kempf C, Ros C.

J Virol. 2010 Nov;84(22):11737-46. doi: 10.1128/JVI.01143-10. Epub 2010 Sep 8.

2.

Parvovirus B19 uptake is a highly selective process controlled by VP1u, a novel determinant of viral tropism.

Leisi R, Ruprecht N, Kempf C, Ros C.

J Virol. 2013 Dec;87(24):13161-7. doi: 10.1128/JVI.02548-13. Epub 2013 Sep 25.

3.

Parvovirus B19 VLP recognizes globoside in supported lipid bilayers.

Nasir W, Nilsson J, Olofsson S, Bally M, Rydell GE.

Virology. 2014 May;456-457:364-9. doi: 10.1016/j.virol.2014.04.004. Epub 2014 Apr 28.

4.

The Receptor-Binding Domain in the VP1u Region of Parvovirus B19.

Leisi R, Di Tommaso C, Kempf C, Ros C.

Viruses. 2016 Feb 24;8(3):61. doi: 10.3390/v8030061.

5.

Antibody-mediated enhancement of parvovirus B19 uptake into endothelial cells mediated by a receptor for complement factor C1q.

von Kietzell K, Pozzuto T, Heilbronn R, Grössl T, Fechner H, Weger S.

J Virol. 2014 Jul;88(14):8102-15. doi: 10.1128/JVI.00649-14. Epub 2014 May 7.

6.

Interaction of parvovirus B19 with human erythrocytes alters virus structure and cell membrane integrity.

Bönsch C, Kempf C, Ros C.

J Virol. 2008 Dec;82(23):11784-91. doi: 10.1128/JVI.01399-08. Epub 2008 Sep 24.

8.
9.

Parvovirus B19 does not bind to membrane-associated globoside in vitro.

Kaufmann B, Baxa U, Chipman PR, Rossmann MG, Modrow S, Seckler R.

Virology. 2005 Feb 5;332(1):189-98.

10.

Erythrocyte P antigen: cellular receptor for B19 parvovirus.

Brown KE, Anderson SM, Young NS.

Science. 1993 Oct 1;262(5130):114-7.

PMID:
8211117
11.

Characterization of the early steps of human parvovirus B19 infection.

Quattrocchi S, Ruprecht N, Bönsch C, Bieli S, Zürcher C, Boller K, Kempf C, Ros C.

J Virol. 2012 Sep;86(17):9274-84. doi: 10.1128/JVI.01004-12. Epub 2012 Jun 20.

12.

Codon optimization of human parvovirus B19 capsid genes greatly increases their expression in nonpermissive cells.

Zhi N, Wan Z, Liu X, Wong S, Kim DJ, Young NS, Kajigaya S.

J Virol. 2010 Dec;84(24):13059-62. doi: 10.1128/JVI.00912-10. Epub 2010 Oct 13.

13.

Molecular mechanism underlying B19 virus inactivation and comparison to other parvoviruses.

Mani B, Gerber M, Lieby P, Boschetti N, Kempf C, Ros C.

Transfusion. 2007 Oct;47(10):1765-74.

PMID:
17880601
14.

Up-regulation of adhesion molecule expression and induction of TNF-alpha on vascular endothelial cells by antibody against human parvovirus B19 VP1 unique region protein.

Tzang BS, Tsai CC, Chiu CC, Shi JY, Hsu TC.

Clin Chim Acta. 2008 Sep;395(1-2):77-83. doi: 10.1016/j.cca.2008.05.012. Epub 2008 May 19.

PMID:
18538665
15.

Molecular and structural characterization of fluorescent human parvovirus B19 virus-like particles.

Gilbert L, Toivola J, White D, Ihalainen T, Smith W, Lindholm L, Vuento M, Oker-Blom C.

Biochem Biophys Res Commun. 2005 Jun 3;331(2):527-35.

PMID:
15850791
16.

Multiple glycosphingolipids determine the tissue tropism of parvovirus B19.

Cooling LL, Koerner TA, Naides SJ.

J Infect Dis. 1995 Nov;172(5):1198-205.

PMID:
7594654
17.

Different susceptibility of B19 virus and mice minute virus to low pH treatment.

Boschetti N, Niederhauser I, Kempf C, Stühler A, Löwer J, Blümel J.

Transfusion. 2004 Jul;44(7):1079-86.

PMID:
15225251
18.

Baculovirus expression of parvovirus B19 (B19V) NS1: utility in confirming recent infection.

Ennis O, Corcoran A, Kavanagh K, Mahon BP, Doyle S.

J Clin Virol. 2001 Aug;22(1):55-60.

PMID:
11418353
19.

The VP1u Receptor Restricts Parvovirus B19 Uptake to Permissive Erythroid Cells.

Leisi R, Von Nordheim M, Ros C, Kempf C.

Viruses. 2016 Sep 28;8(10). pii: E265.

20.

Supplemental Content

Support Center